Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction

Atherosclerosis

Volumn 221, Issue 1, 2012, Pages 226-231

  Jung, Christian ^a   Sörensson, Peder ^a   Saleh, Nawsad ^a   Arheden, Håkan ^b   Rydén, Lars ^a   Pernow, John ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Acute myocardial infarction; Endothelial microparticles; Hypoxia; Ischemia

Indexed keywords

CD31 ANTIGEN; GLYCOPROTEIN; VASCULAR ENDOTHELIAL CADHERIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL ARTICLE; ENDOTHELIUM INJURY; FEMALE; FLOW CYTOMETRY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION;

AGED; ANTIGENS, CD; ANTIGENS, CD31; BIOLOGICAL MARKERS; BLOOD PLATELETS; CADHERINS; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; SWEDEN;

EID: 84857031342     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.12.025     Document Type: Article

References (46)

1. Thomas D., Giugliano R.P. Management of ST-segment elevation myocardial infarction: comparison of the updated guidelines from North America and Europe. Am Heart J 2009, 158:695-705.
2. Lev E.I., Kornowski R., Vaknin-Assa H., et al. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2008, 102:6-11.
3. Roubille F., Samri A., Cornillet L., et al. Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI. Eur J Intern Med 2010, 21:131-136.
4. Lundberg J.O., Carlstrom M., Larsen F.J., Weitzberg E. Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc Res 2011, 89:525-532.
5. Jung C., Gonon A.T., Sjoquist P.O., Lundberg J.O., Pernow J. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. Cardiovasc Res 2010, 85:147-154.
6. Blann A., Shantsila E., Shantsila A. Microparticles and arterial disease. Semin Thromb Hemost 2009, 35:488-496.
7. Koga H., Sugiyama S., Kugiyama K., et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005, 45:1622-1630.
8. Bulut D., Maier K., Bulut-Streich N., et al. Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction. J Card Fail 2008, 14:336-340.
9. Bernal-Mizrachi L., Jy W., Jimenez J.J., et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003, 145:962-970.
10. Zielinska M., Koniarek W., Goch J.H., et al. Circulating endothelial microparticles in patients with acute myocardial infarction. Kardiol Pol 2005, 62:531-542. discussion 543-534.
11. Katopodis J.N., Kolodny L., Jy W., et al. Platelet microparticles and calcium homeostasis in acute coronary ischemias. Am J Hematol 1997, 54:95-101.
12. Michelsen A.E., Brodin E., Brosstad F., Hansen J.B. Increased level of platelet microparticles in survivors of myocardial infarction. Scand J Clin Lab Invest 2008, 68:386-392.
13. Nomura S., Uehata S., Saito S., et al. Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost 2003, 89:506-512.
14. Ramacciotti E., Hawley A.E., Farris D.M., et al. Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb Haemost 2009, 101:748-754.
15. Rentrop K.P., Cohen M., Blanke H., Phillips R.A. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985, 5:587-592.
16. Engblom H., Hedström E., Heiberg E., et al. Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone: one-year follow-up by MRI. Circ Cardiovasc Imaging 2009, 2:47-55.
17. Heiberg E., Ugander M., Engblom H., et al. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Radiology 2008, 246:581-588.
18. Sorensson P., Heiberg E., Saleh N., et al. Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography. J Cardiovasc Magn Reson 2010, 12:25.
19. Heiberg E., Sjögren J., Ugander M., et al. Design and validation of segment-freely available software for cardiovascular image analysis. BMC Med Imaging 2010, 11:1.
20. Shah M.D., Bergeron A.L., Dong J.F., Lopez J.A. Flow cytometric measurement of microparticles: pitfalls and protocol modifications. Platelets 2008, 19:365-372.
21. van Ierssel S.H., Van Craenenbroeck E.M., Conraads V.M., et al. Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied. Thromb Res 2010, 125:332-339.
22. Jung C., Shemyakin A., Bohm F., Pernow J. Endothelial microparticles in patients with insulin resistance. Diabetes Metab 2009, 35:71-73.
23. - microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 2006, 26:2530-2535.
24. Combes V., Simon A.C., Grau G.E., et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999, 104:93-102.
25. Lincz L.F., Scorgie F.E., Enjeti A., Seldon M. Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V Leiden. Thromb Res 2011.
26. Deregibus M.C., Cantaluppi V., Calogero R., et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007, 110:2440-2448.
27. Leroyer A.S., Ebrahimian T.G., Cochain C., et al. Microparticles from ischemic muscle promotes postnatal vasculogenesis. Circulation 2009, 119:2808-2817.
28. Huisse M.G., Lanoy E., Tcheche D., et al. Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarction. Thromb Haemost 2007, 98:420-426.
29. Simak J., Gelderman M.P., Yu H., Wright V., Baird A.E. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006, 4:1296-1302.
30. Priou P., Gagnadoux F., Tesse A., et al. Endothelial dysfunction and circulating microparticles from patients with obstructive sleep apnea. Am J Pathol 2010, 177:974-983.
31. Nomura S., Ozaki Y., Ikeda Y. Function and role of microparticles in various clinical settings. Thromb Res 2008, 123:8-23.
32. Jung C., Rafnsson A., Shemyakin A., Bohm F., Pernow J. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes. Int J Cardiol 2010, 3:368-372.
33. Bernard S., Loffroy R., Serusclat A., Boussel L., Bonnefoy E., Thevenon C., Rabilloud M., Revel D., Moulin P., Douek P. Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary non-calcified plaques evaluated by multidetector computed tomography (MDCT). Atherosclerosis 2009, 203:429-435.
34. Amabile N., Heiss C., Chang V., et al. Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant 2009, 28:1081-1086.
35. Philippova M., Suter Y., Toggweiler S., Schoenenberger A.W., Joshi M.B., Kyriakakis E., Erne P., Resink T.J. T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis. Eur Heart J 2011, 32:760-771.
36. - microparticles are associated with impaired systemic artery elasticity in healthy subjects. Am J Hypertens 2007, 20:957-964.
37. - microparticles is associated with improvement of endothelial function in humans. Eur J Pharmacol 2009, 614:77-83.
38. Jimenez J.J., Jy W., Mauro L.M., et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003, 109:175-180.
39. Rautou P.E., Vion A.C., Amabile N., et al. Microparticles, vascular function and atherothrombosis. Circ Res 2011, 109:593-606.
40. Puddu P., Puddu G.M., Cravero E., Muscari S., Muscari A. The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol 2003, 26:140-145.
41. Dignat-George F., Boulanger C.M. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011, 31:27-33.
42. Tushuizen M.E., Diamant M., Sturk A., Nieuwland R. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?. Arterioscler Thromb Vasc Biol 2011, 31:4-9.
43. Leroyer A.S., Anfosso F., Lacroix R., et al. Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost 2010, 104:456-463.
44. Porto I., Leone A.M., De Maria G.L., et al. Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study. Atherosclerosis 2011, 216:355-358.
45. Benameur T., Tual-Chalot S., Andriantsitohaina R., Martinez M.C. PPARalpha is essential for microparticle-induced differentiation of mouse bone marrow-derived endothelial progenitor cells and angiogenesis. PLoS One 2010, 5:e12392.
46. Turer A.T., Addo T.A., Martin J.L., et al. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study. J Am Coll Cardiol 2011, 57:2398-2405.